UNICYCIVE THERAPEUTICS, INC. Depreciation
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Depreciation of $14.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-12
- UNICYCIVE THERAPEUTICS, INC. depreciation for the quarter ending 2026-06-30 was $6.00K, a 0.00% change year-over-year.
- UNICYCIVE THERAPEUTICS, INC. depreciation for the quarter ending 2026-03-31 was $8.00K, a 0.00% change year-over-year.
- UNICYCIVE THERAPEUTICS, INC. depreciation for the quarter ending 2025-12-31 was $10.00K, a 42.86% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. depreciation for the quarter ending 2025-09-30 was $10.00K, a 66.67% increase year-over-year.
- UNICYCIVE THERAPEUTICS, INC. depreciation for fiscal 2025 was $34.00K, a 54.55% increase from fiscal 2024.
- UNICYCIVE THERAPEUTICS, INC. depreciation for fiscal 2024 was $22.00K, a 144.44% increase from fiscal 2023.
- UNICYCIVE THERAPEUTICS, INC. depreciation for fiscal 2023 was $9.00K, a 28.57% increase from fiscal 2022.
- UNICYCIVE THERAPEUTICS, INC. depreciation for fiscal 2022 was $7.00K, a 600.00% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $14.00K 10-Q · filed 2026-08-12 | $24.00K derived: sum of 3 quarters · filed 2026-08-12 | $34.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $8.00K 10-Q · filed 2026-05-12 | $18.00K derived: sum of 2 quarters · filed 2026-05-12 | $28.00K derived: sum of 3 quarters · filed 2026-05-12 | $34.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $20.00K derived: sum of 2 quarters · filed 2026-03-30 | $26.00K derived: sum of 3 quarters · filed 2026-08-12 | $34.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $16.00K derived: sum of 2 quarters · filed 2026-08-12 | $24.00K 10-Q · filed 2025-11-12 | $31.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $14.00K 10-Q · filed 2026-08-12 | $21.00K derived: sum of 3 quarters · filed 2026-08-12 | $27.00K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $8.00K 10-Q · filed 2026-05-12 | $15.00K derived: sum of 2 quarters · filed 2026-05-12 | $21.00K derived: sum of 3 quarters · filed 2026-05-12 | $21.00K derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $13.00K derived: sum of 2 quarters · filed 2026-03-30 | $13.00K derived: sum of 3 quarters · filed 2026-03-30 | $22.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $6.00K derived: sum of 2 quarters · filed 2025-11-12 | $15.00K 10-Q · filed 2025-11-12 | $18.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $9.00K 10-Q · filed 2025-08-14 | $12.00K derived: sum of 3 quarters · filed 2025-08-14 | $14.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-14 | $12.00K derived: sum of 2 quarters · filed 2025-05-14 | $14.00K derived: sum of 3 quarters · filed 2025-05-14 | $16.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.00K derived: sum of 2 quarters · filed 2025-03-31 | $7.00K derived: sum of 3 quarters · filed 2025-03-31 | $9.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $4.00K derived: sum of 2 quarters · filed 2024-11-13 | $6.00K 10-Q · filed 2024-11-13 | $8.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $4.00K 10-Q · filed 2024-08-14 | $6.00K derived: sum of 3 quarters · filed 2024-08-14 | $7.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-13 | $4.00K derived: sum of 2 quarters · filed 2024-05-13 | $5.00K derived: sum of 3 quarters · filed 2024-05-13 | $7.00K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.00K derived: sum of 2 quarters · filed 2024-03-28 | $5.00K derived: sum of 3 quarters · filed 2024-03-28 | $7.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.00K derived: sum of 2 quarters · filed 2023-11-14 | $5.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.00K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-16 | ||||
| 2021-12-31 | $1.00K 10-K · filed 2023-03-31 | $468.00K 10-K · filed 2022-03-31 | |||
| 2020-12-31 | $63.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |